Mario Alberto Alarcón-Sánchez, Ruth Rodríguez-Montaño, Sarah Monserrat Lomelí-Martínez, Cristina Hermila Martínez-Bugarin, Seyed Ali Mosaddad, Artak Heboyan
{"title":"慢性牙周炎患者唾液和血浆toll样受体2和4水平升高吗?:系统回顾与元分析。","authors":"Mario Alberto Alarcón-Sánchez, Ruth Rodríguez-Montaño, Sarah Monserrat Lomelí-Martínez, Cristina Hermila Martínez-Bugarin, Seyed Ali Mosaddad, Artak Heboyan","doi":"10.1155/ijin/7405066","DOIUrl":null,"url":null,"abstract":"<p><p>Toll-like receptors (TLR2 and TLR4) are crucial in the detection of pathogen-associated molecular patterns (PAMPs) during periodontitis, resulting in exacerbated production of proinflammatory cytokines and ultimately tissue damage and bone loss associated with this periodontal disease. This systematic review and meta-analysis aimed to systematically analyze and quantify the differences between TLR2 and TLR4 levels in the saliva and plasma of individuals with chronic periodontitis (CP) and systemically and periodontally healthy subjects (SPHS). The databases consulted were Scopus, Web of Science, and PubMed from 2011 to 2024 to locate cross-sectional studies that measured TLR2 and TLR4 levels. Studies selected were human research articles published in English, evaluating these biomarkers through ELISA. Data were extracted, and the quality of studies was appraised using the Joanna Briggs Institute (JBI) tool for observational studies. Meta-analyses were executed using STATA V.15 (StataCorp LP, College Station, Texas) employing fixed or random-effects models based on the degree of heterogeneity using I<sup>2</sup> statistics. Out of 404 articles found, four studies were included for both qualitative and quantitative synthesis. We found an increase in salivary TLR4 levels in subjects with CP compared with SPHS (SMD = 265.217 (95% confidence interval (CI) = 109.311-421.122); <i>p</i>=0.001). As well as an increase in plasma levels of TLR4 in subjects with CP compared with SPHS (SMD = 2.93 (95% CI = 1.57-4.29); <i>p</i>=0.001). TLR4 concentrations in saliva and plasma of subjects with CP were higher than those observed in the healthy population. However, further validation in larger prospective studies is needed before clinical implementation.</p>","PeriodicalId":14004,"journal":{"name":"International Journal of Inflammation","volume":"2025 ","pages":"7405066"},"PeriodicalIF":2.6000,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12074830/pdf/","citationCount":"0","resultStr":"{\"title\":\"Are Salivary and Plasma Levels of Toll-Like Receptors 2 and 4 Elevated in Subjects With Chronic Periodontitis?: A Systematic Review and Meta-Analysis.\",\"authors\":\"Mario Alberto Alarcón-Sánchez, Ruth Rodríguez-Montaño, Sarah Monserrat Lomelí-Martínez, Cristina Hermila Martínez-Bugarin, Seyed Ali Mosaddad, Artak Heboyan\",\"doi\":\"10.1155/ijin/7405066\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Toll-like receptors (TLR2 and TLR4) are crucial in the detection of pathogen-associated molecular patterns (PAMPs) during periodontitis, resulting in exacerbated production of proinflammatory cytokines and ultimately tissue damage and bone loss associated with this periodontal disease. This systematic review and meta-analysis aimed to systematically analyze and quantify the differences between TLR2 and TLR4 levels in the saliva and plasma of individuals with chronic periodontitis (CP) and systemically and periodontally healthy subjects (SPHS). The databases consulted were Scopus, Web of Science, and PubMed from 2011 to 2024 to locate cross-sectional studies that measured TLR2 and TLR4 levels. Studies selected were human research articles published in English, evaluating these biomarkers through ELISA. Data were extracted, and the quality of studies was appraised using the Joanna Briggs Institute (JBI) tool for observational studies. Meta-analyses were executed using STATA V.15 (StataCorp LP, College Station, Texas) employing fixed or random-effects models based on the degree of heterogeneity using I<sup>2</sup> statistics. Out of 404 articles found, four studies were included for both qualitative and quantitative synthesis. We found an increase in salivary TLR4 levels in subjects with CP compared with SPHS (SMD = 265.217 (95% confidence interval (CI) = 109.311-421.122); <i>p</i>=0.001). As well as an increase in plasma levels of TLR4 in subjects with CP compared with SPHS (SMD = 2.93 (95% CI = 1.57-4.29); <i>p</i>=0.001). TLR4 concentrations in saliva and plasma of subjects with CP were higher than those observed in the healthy population. However, further validation in larger prospective studies is needed before clinical implementation.</p>\",\"PeriodicalId\":14004,\"journal\":{\"name\":\"International Journal of Inflammation\",\"volume\":\"2025 \",\"pages\":\"7405066\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2025-05-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12074830/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Inflammation\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1155/ijin/7405066\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Inflammation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/ijin/7405066","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
toll样受体(TLR2和TLR4)在牙周炎期间检测病原体相关分子模式(PAMPs)中起着至关重要的作用,导致促炎细胞因子的产生加剧,最终导致与牙周病相关的组织损伤和骨质流失。本系统综述和荟萃分析旨在系统分析和量化慢性牙周炎(CP)患者与全身和牙周健康受试者(SPHS)唾液和血浆中TLR2和TLR4水平的差异。查阅了2011年至2024年Scopus、Web of Science和PubMed数据库,以定位测量TLR2和TLR4水平的横断面研究。选择的研究是用英文发表的人类研究文章,通过ELISA评估这些生物标志物。提取数据,并使用乔安娜布里格斯研究所(JBI)观察性研究工具评估研究质量。meta分析采用STATA V.15 (StataCorp LP, College Station, Texas),采用基于I2统计异质性程度的固定或随机效应模型。在发现的404篇文章中,有4篇研究被纳入定性和定量综合。我们发现,与SPHS患者相比,CP患者唾液中TLR4水平升高(SMD = 265.217(95%可信区间(CI) = 109.311-421.122);p = 0.001)。与SPHS患者相比,CP患者血浆中TLR4水平升高(SMD = 2.93 (95% CI = 1.57-4.29);p = 0.001)。CP患者唾液和血浆中TLR4浓度高于健康人群。然而,在临床应用之前,需要在更大规模的前瞻性研究中进一步验证。
Are Salivary and Plasma Levels of Toll-Like Receptors 2 and 4 Elevated in Subjects With Chronic Periodontitis?: A Systematic Review and Meta-Analysis.
Toll-like receptors (TLR2 and TLR4) are crucial in the detection of pathogen-associated molecular patterns (PAMPs) during periodontitis, resulting in exacerbated production of proinflammatory cytokines and ultimately tissue damage and bone loss associated with this periodontal disease. This systematic review and meta-analysis aimed to systematically analyze and quantify the differences between TLR2 and TLR4 levels in the saliva and plasma of individuals with chronic periodontitis (CP) and systemically and periodontally healthy subjects (SPHS). The databases consulted were Scopus, Web of Science, and PubMed from 2011 to 2024 to locate cross-sectional studies that measured TLR2 and TLR4 levels. Studies selected were human research articles published in English, evaluating these biomarkers through ELISA. Data were extracted, and the quality of studies was appraised using the Joanna Briggs Institute (JBI) tool for observational studies. Meta-analyses were executed using STATA V.15 (StataCorp LP, College Station, Texas) employing fixed or random-effects models based on the degree of heterogeneity using I2 statistics. Out of 404 articles found, four studies were included for both qualitative and quantitative synthesis. We found an increase in salivary TLR4 levels in subjects with CP compared with SPHS (SMD = 265.217 (95% confidence interval (CI) = 109.311-421.122); p=0.001). As well as an increase in plasma levels of TLR4 in subjects with CP compared with SPHS (SMD = 2.93 (95% CI = 1.57-4.29); p=0.001). TLR4 concentrations in saliva and plasma of subjects with CP were higher than those observed in the healthy population. However, further validation in larger prospective studies is needed before clinical implementation.